Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE W DEXTROSE 4 25 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DIALYTE W/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intraperitoneal administration of dextrose creates an osmotic gradient that promotes ultrafiltration and removal of uremic toxins and excess fluid across the peritoneal membrane, while electrolytes in the solution correct imbalances.
Dianeal PD-2 with Dextrose 3.5% is a peritoneal dialysis solution. Dextrose provides an osmotic gradient that facilitates the removal of uremic toxins and excess fluid from the blood across the peritoneal membrane into the dialysate. The solution also contains electrolytes to correct imbalances.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges per day, via continuous ambulatory peritoneal dialysis (CAPD).
2 to 3 liters intraperitoneally, 4 exchanges daily, with dwell times of 4-6 hours for CAPD; or 2 to 2.5 liters intraperitoneally, cycler-assisted, 3-5 cycles nightly for APD. Dextrose 3.5% solution used based on ultrafiltration needs.
None Documented
None Documented
Not applicable (combination product); dextrose follows glucose kinetics (~1.5–2 h); electrolytes have no half-life.
The elimination half-life of dextrose from the systemic circulation is approximately 3.5-4.5 hours after intraperitoneal administration. Clinically, this reflects the rate of glucose absorption and metabolism, which can be altered in patients with impaired glucose tolerance or diabetes.
Primarily renal; glucose is reabsorbed or metabolized; electrolytes follow renal handling. Not applicable as a drug; dialysate components are removed via peritoneal dialysis effluent.
Peritoneal dialysis (PD) with 3.5% dextrose solution results in elimination of excess fluid and solutes via the peritoneal membrane. Dextrose is absorbed systemically and metabolized. The primary route of elimination of dialytic waste products (e.g., urea, creatinine) is via the peritoneal fluid itself, which is drained. Less than 1% of dextrose is excreted unchanged in urine. Biliary/fecal excretion is negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution